Thermo Fisher Scientific Share Buybacks increased by 8008.1% to $3.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $2.00B to $3.00B.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q1 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00B | $1.00B | $3.00B | $3.00B | $1.00B | $2.00B | $0.00 | $963.00M | $37.00M | $3.00B |
| QoQ Change | — | -50.0% | +200.0% | +0.0% | -66.7% | +100.0% | -100.0% | — | -96.2% | >999% |
| YoY Change | — | — | +50.0% | +0.0% | — | -33.3% | — | — | -96.3% | +50.0% |